Sporothrix schenckii: Difference between revisions
| Line 44: | Line 44: | ||
==Pathology== | ==Pathology== | ||
How does this organism cause disease? Human, animal, plant hosts? Virulence factors, as well as patient symptoms. | How does this organism cause disease? Human, animal, plant hosts? Virulence factors, as well as patient symptoms. | ||
Sporothrix schenckii is the causative agent of sporotrichosis ("rose handler's disease") [1909]. Sporotrichosis is a subcutaneous infection with a common chronic and a rare progressive course. The infection starts following entry of the infecting fungus through the skin via a minor trauma and may affect an otherwise healthy individual. Following entry, the infection may spread via the lymphatic route. Nodular lymphangitis may develop [1240, 2242]. Interestingly, an epidemic of sporotrichosis after sleeping in a rust-stained camping tent has been reported and the tent was identified as the source of infection [369]. Patients infected with Sporothrix schenckii may be misdiagnosed as pyoderma gangrenosum due to the large ulcerations observed during the course of sporotrichosis [354]. | |||
Pulmonary [672, 879, 1164] and osteoarticular infections [647, 1322], granulamatous tenosynovitis and carpal tunnel syndrome [2178], bursal infection [2374], endophthalmitis [1266, 2450], meningitis [698, 1752], invasive sinusitis [1574], and disseminated [1575, 2377] sporotrichosis have been described. The infection remains localized in immunocompetent individuals while fungemia and disseminated infection may be observed in immunocompromised patients, such as those with AIDS [39, 647, 856, 1266, 1354, 1574, 1752, 2377]. Fatal fungemia may develop also in patients with diabetes mellitus and alcoholism [398]. Primary (granulamatous) pneumonia without any cutaneous disease may develop in alcoholics [672]. Laboratory-acquired sporotrichosis has also been reported. | |||
Fugomyces cyanescens is frequently considered to be nonpathogenic. It is avirulent in animal models and human cases in general do not suggest a clinical syndrome [2104]. However, pulmonary lesions and pneumonia due to Fugomyces cyanescens have been reported in organ transplant recipients | |||
==Application to Biotechnology== | ==Application to Biotechnology== | ||
Revision as of 23:17, 19 August 2007
A Microbial Biorealm page on the genus Sporothrix schenckii
Classification(1)
Higher order taxa
cellular organisms; Eukaryota; KINGDOM: Fungi/Metazoa group; Fungi; Dikarya; PHYLUM: Ascomycota; SUBDIVISION: Pezizomycotina; CLASS: Sordariomycetes; SUBCLASS: Sordariomycetidae; ORDER: Ophiostomatales; FAMILY: Ophiostomataceae; mitosporic Ophiostomataceae; GENUS: Sporothrix
Species
|
NCBI: Taxonomy |
Sporothrix schenckii
Description and significance
Describe the appearance, habitat, etc. of the organism, and why it is important enough to have its genome sequenced. Describe how and where it was isolated. Include a picture or two (with sources) if you can find them.
Sporothrix is a thermally dimorphic fungus which is distributed worldwide and isolated from soil, living and decomposing plants, woods, and peat moss. Sporothrix schenckii is an occasional cause of human infections. Ophiostoma stenoceras is the teleomorph of Sporothrix sp.
Despite the existence of the fungus worldwide, infections due to Sporothrix schenckii are more common at certain geographical areas. Peru is an area of hyperendemicity for Sporothrix schenckii infections The genus Sporothrix contains one active species, Sporothrix schenckii.
The species cyanescens, formerly classified in genus Sporothrix, was later included in genus Cerinosterus and now is classified in genus Fugomyces. Accordingly, the former Sporothrix cyanescens is now referred to as Fugomyces cyanescens, which is a basidiomycetous genus unlike the ascomycetous Sporothrix. You may want to refer to our synonym and classification page for more details and history of this taxonomic modification to genus Fugomyces.
Sporothrix schenckii is the pathogenic species, while Fugomyces cyanescens is considered to be nonpathogenic. Macroscopic and microscopic features of these species are different from each other. Sporothrix schenckii is a thermally dimorphic fungus. The nonpathogenic Sporothrix sp., on the other hand, may occasionally convert to a yeast phase at 37°C (2) In mammalian tissues, S. schenckii is yeast-like, appearing as spherical or cigar-shaped bodies measuring 4 to 6 μm in length that reproduce by budding (7). However, direct microscopic identification of the organism in biopsy sections is always difficult because of the paucity of the organism (3)
Genome structure
Describe the size and content of the genome. How many chromosomes? Circular or linear? Other interesting features? What is known about its sequence? Does it have any plasmids? Are they important to the organism's lifestyle?
Cell structure and metabolism
Describe any interesting features and/or cell structures; how it gains energy; what important molecules it produces.
Ecology
Describe any interactions with other organisms (included eukaryotes), contributions to the environment, effect on environment, etc.
Pathology
How does this organism cause disease? Human, animal, plant hosts? Virulence factors, as well as patient symptoms.
Sporothrix schenckii is the causative agent of sporotrichosis ("rose handler's disease") [1909]. Sporotrichosis is a subcutaneous infection with a common chronic and a rare progressive course. The infection starts following entry of the infecting fungus through the skin via a minor trauma and may affect an otherwise healthy individual. Following entry, the infection may spread via the lymphatic route. Nodular lymphangitis may develop [1240, 2242]. Interestingly, an epidemic of sporotrichosis after sleeping in a rust-stained camping tent has been reported and the tent was identified as the source of infection [369]. Patients infected with Sporothrix schenckii may be misdiagnosed as pyoderma gangrenosum due to the large ulcerations observed during the course of sporotrichosis [354].
Pulmonary [672, 879, 1164] and osteoarticular infections [647, 1322], granulamatous tenosynovitis and carpal tunnel syndrome [2178], bursal infection [2374], endophthalmitis [1266, 2450], meningitis [698, 1752], invasive sinusitis [1574], and disseminated [1575, 2377] sporotrichosis have been described. The infection remains localized in immunocompetent individuals while fungemia and disseminated infection may be observed in immunocompromised patients, such as those with AIDS [39, 647, 856, 1266, 1354, 1574, 1752, 2377]. Fatal fungemia may develop also in patients with diabetes mellitus and alcoholism [398]. Primary (granulamatous) pneumonia without any cutaneous disease may develop in alcoholics [672]. Laboratory-acquired sporotrichosis has also been reported.
Fugomyces cyanescens is frequently considered to be nonpathogenic. It is avirulent in animal models and human cases in general do not suggest a clinical syndrome [2104]. However, pulmonary lesions and pneumonia due to Fugomyces cyanescens have been reported in organ transplant recipients
Application to Biotechnology
Does this organism produce any useful compounds or enzymes? What are they and how are they used?
Current Research
Enter summaries of the most recent research here--at least three required
References
(1) NCBI: Sporothrix schenckii, Accessed August 15, 2007, <http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&id=29908&lvl=3&lin=f&keep=1&srchmode=1&unlock>
Edited by Whitney Johnson-Courtright of Rachel Larsen
